Short Description

NGS genetic DNA test detecets for variant and mutation detection in SRGAP1 gene for Thyroid cancer type 2, nonmedullary, susceptibility to

PreTest Information

Clinical History of Patient who is going for SRGAP1 Gene Thyroid cancer type 2, nonmedullary, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SRGAP1 Gene Thyroid cancer type 2, nonmedullary, susceptibility to NGS Genetic DNA Test gene SRGAP1

Detail Description

SRGAP1 Gene and Thyroid Cancer Type 2: Understanding Susceptibility with NGS Genetic DNA Test

Thyroid cancer is one of the most common types of cancer, with an estimated 52,890 new cases expected in the United States in 2021 alone. While it can affect anyone, certain genetic mutations can increase an individual's susceptibility to developing thyroid cancer. One such mutation is found in the SRGAP1 gene, which is linked to nonmedullary thyroid cancer type 2.

What is SRGAP1 Gene?

The SRGAP1 gene, also known as SLIT-ROBO Rho GTPase-activating protein 1, is located on chromosome 1 and is responsible for producing a protein that regulates the development and function of nerve cells. Recent research has also identified a link between the SRGAP1 gene and thyroid cancer susceptibility.

Thyroid Cancer Type 2 and SRGAP1 Gene

Nonmedullary thyroid cancer type 2 (NMTC2) is a subtype of thyroid cancer that is linked to genetic mutations, including those in the SRGAP1 gene. Individuals with this mutation have an increased risk of developing NMTC2, which accounts for approximately 5-10% of all thyroid cancer cases.

Symptoms and Diagnosis of Thyroid Cancer

The symptoms of thyroid cancer can vary depending on the subtype and stage of the disease. Some common symptoms include:

• A lump or swelling in the neck
• Difficulty swallowing or breathing
• Hoarseness or other voice changes
• Pain in the neck or throat
• Swollen lymph nodes in the neck

If you are experiencing any of these symptoms, it is important to see a doctor for evaluation and diagnosis. Diagnosis typically involves a physical exam, blood tests, imaging tests such as ultrasound or CT scans, and a biopsy of any suspicious tissue.

NGS Genetic DNA Test for SRGAP1 Gene and Thyroid Cancer Susceptibility

If you have a family history of thyroid cancer or are experiencing symptoms, you may be interested in a genetic test to determine your risk of developing the disease. A Next-Generation Sequencing (NGS) Genetic DNA Test can identify mutations in the SRGAP1 gene and other genes associated with thyroid cancer susceptibility.

The cost of an NGS Genetic DNA Test for SRGAP1 gene and thyroid cancer susceptibility in India is typically around INR 20,000. This test can provide valuable information about your risk for developing thyroid cancer, allowing you to take proactive steps to manage your health.

Conclusion

The SRGAP1 gene is linked to nonmedullary thyroid cancer type 2, a subtype of thyroid cancer that is associated with genetic mutations. If you are experiencing symptoms or have a family history of thyroid cancer, consider talking to your doctor about an NGS Genetic DNA Test for SRGAP1 gene and thyroid cancer susceptibility. With early detection and management, thyroid cancer can often be successfully treated.

Remember to always prioritize your health and seek medical advice if you have any concerns.

Before getting tested ask for Raw Data, FASTQ, and VCF files along with clinical test report from DNA Testing Lab. DNA Labs India is the Only lab that is transparent and will share Raw Data, FASTQ, and VCF files along with the conclusive clinical report for SRGAP1 Gene Thyroid cancer type 2, nonmedullary, susceptibility to NGS Genetic DNA Test